Add BrightSurf on Google Email

Preparing for the next pandemic: Harmonize vaccinations in Canada

A proposed Canadian Immunization Services model could provide a coordinated approach to vaccination across the country, addressing fragmentation in data sharing, vaccine procurement, and supply chain management. The independent not-for-profit corporation would be funded by provinces, territories, and potentially the federal government.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·DateJul 19, 2021

COVID-19 vaccination: Examining negative dominance on social media

A recent study published in the Disaster Medicine and Public Health Preparedness journal explores negative dominance of COVID-19 vaccine-related information online. The researchers found that compared to all other content, posts focused on adverse events pale in comparison to posts promoting positive messages about vaccines.

SourceSociety for Disaster Medicine and Public Health, Inc.·JournalDisaster Medicine and Public Health Preparedness·DateJul 16, 2021

Primary care provides clinical guidance, answers about COVID-19 testing, vaccine

Primary care physicians provide the largest share of services for vaccinations and majority of clinical visits for vaccination, making them well-positioned to administer COVID-19 vaccines. They can also answer vaccine questions and provide clinical guidance on interpreting results from COVID-19 testing and immunity determinations.

SourceAmerican Academy of Family Physicians·JournalThe Annals of Family Medicine·DateJul 14, 2021

Allocating COVID vaccines based on health and socioeconomic factors could cut mortality

A recent study by Columbia University's Mailman School of Public Health found that 43% of US COVID-19 mortality variability is linked to county-level socioeconomic indicators and health vulnerabilities. Allocating vaccines to these areas could minimize severe outcomes, particularly deaths. The research suggests a correlation between he...

Study of antibodies produced in saliva after Pfizer COVID vaccine shows both importance of second vaccine dose and updating vaccines to combat new variants of concern

Researchers found that vaccination significantly increases neutralizing antibodies in saliva, reducing transmission risk. The study also shows the importance of receiving a second vaccine dose for maximum protection against evolving virus strains.

Pfizer-BioNTech vaccine in patients undergoing cancer treatment

A recent study published in JAMA Oncology found that the Pfizer-BioNTech vaccine appears to be safe and effective in patients with cancer, achieving satisfactory serologic status. Despite a lag in antibody production compared to non-cancer control groups, most patients experienced seroconversion after the second dose.

SourceJAMA Network·JournalJAMA Oncology·DateJul 8, 2021

CoronaVac vaccine provides 83.5% protection against symptomatic COVID-19 and 100% protection against hospitalization, interim analysis reveals

The CoronaVac vaccine demonstrated 83.5% protection against symptomatic COVID-19 and 100% effectiveness against hospitalization in a phase 3 trial. The study involved adults aged 18-59 and showed high efficacy with a very good safety profile, but further data is needed on the vaccine's long-term effects and efficacy against new variants.

Partnering with Black faith leaders and pharmacists increases COVID-19 vaccine uptake among Black communities, California study suggests

A California study suggests that partnering with black churches and medical professionals can increase COVID-19 vaccine uptake in black communities. The study found that a three-tier approach to mobile vaccination clinics, involving faith leaders and pharmacists, resulted in a significant increase in vaccine uptake among blacks.

Biomaterial vaccines ward off broad range of bacterial infections and septic shock

Researchers developed a biomaterial-based infection vaccine (ciVAX) approach to combat infectious diseases. ciVAX vaccines combine two technologies that capture immunogenic antigens from pathogens and reprogram the immune system, offering potential solutions for sepsis prophylaxis, pandemic threats, and biothreats.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalNature Biomedical Engineering·DateJul 8, 2021

Antibody but not T-cell response after first dose of Pfizer COVID-19 vaccine is weakened in patients receiving methotrexate

A new study found that patients taking immunosuppressants like methotrexate had weaker antibody responses to the Pfizer COVID-19 vaccine after the first dose. However, T-cell responses were preserved in these patients, suggesting potential risks and benefits of vaccinating immunocompromised individuals.

Context in science reporting affects beliefs about, and support for, science

A new study led by a University at Buffalo researcher shows that the way news media talk about science focuses too much attention on individuals, leading to inaccurate perceptions of scientific accuracy and reliability. The study suggests that contextualizing failure stories within the scientific process can help ameliorate harm to sci...

SourceUniversity at Buffalo·JournalPublic Understanding of Science·DateJul 6, 2021

83% of the Spanish population trusts in vaccination against COVID, 25 points more than in January

The Spanish Foundation for Science and Technology's third Social Perception Survey reveals that 83% of the population trusts COVID-19 vaccination, a 25-point increase from January. Attitudes towards vaccine uptake have improved significantly since July 2020, with compliance with COVID-19 preventive measures also showing a positive trend.